Mutations of DNA damage repair genes including BRCA2, BRCA1 [4, 5], ATM [6], and/or mismatch repair (MMR) genes are associated with an increased incidence of prostate cancer [7–9]. The gene discussed is BRCA2; the disease is prostate carcinoma.